The Economist has a story following a PLoS Medicine paper from John Ioannidis and colleagues which argues that scientific publishing may be biased toward high-profile papers that may have less accurate findings. "With so many scientific papers chasing so few pages in the most prestigious journals, the winners could be the ones most likely to oversell themselves," the article says.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.